| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2008;52:542.)
© 2008 American Heart Association, Inc.
Original Articles |
From the Department of Physiology and Biophysics (M.F.D.-P., R.A.S.S., E.R.M.G., M.N.M.A., P.W.M.A., L.G., M.R., B.F., S.G.), Federal University of Minas Gerais, Belo Horizonte, Brazil; and the Max-Delbrück Center for Molecular Medicine (M.B., N.A.), Berlin, Germany.
Correspondence to Silvia Guatimosim, Institute of Biological Sciences, Federal University of Minas Gerais, Av Antônio Carlos 6627, Belo Horizonte, MG-CEP 31270-901, Brazil. E-mail guatimosim{at}icb.ufmg.br
Recently there has been growing evidence suggesting that beneficial effects of angiotensin-(1-7) [Ang-(1-7)] in the heart are mediated by its receptor Mas. However, the signaling pathways involved in these effects in cardiomyocytes are unknown. Here, we investigated the involvement of the Ang-(1-7)/Mas axis in NO generation and Ca2+ handling in adult ventricular myocytes using a combination of molecular biology, intracellular Ca2+ imaging, and confocal microscopy. Acute Ang-(1-7) treatment (10 nmol/L) leads to NO production and activates endothelial NO synthase and Akt in cardiomyocytes. Ang-(1-7)–dependent NO raise was abolished by pretreatment with A-779 (1 µmol/L). To confirm that Ang-(1-7) action is mediated by Mas, we used cardiomyocytes isolated from Mas-deficient mice. In Mas-deficient cardiomyocytes, Ang-(1-7) failed to increase NO levels. Moreover, Mas-ablation was accompanied by significant alterations in the proteins involved in the regulation of endothelial NO synthase activity, indicating that endothelial NO synthase and its binding partners are important effectors of the Mas-mediated pathway in cardiomyocytes. We then investigated the role of the Ang-(1-7)/Mas axis on Ca2+ signaling. Cardiomyocytes treated with 10 nmol/L of Ang-(1-7) did not show changes in Ca2+-transient parameters such as peak Ca2+ transients and kinetics of decay. Nevertheless, cardiomyocytes from Mas-deficient mice presented reduced peak and slower [Ca2+]i transients when compared with wild-type cardiomyocytes. Lower Ca2+ ATPase of the sarcoplasmic reticulum expression levels accompanied the reduced Ca2+ transient in Mas-deficient cardiomyocytes. Therefore, chronic Mas-deficiency leads to impaired Ca2+ handling in cardiomyocytes. Collectively, these observations reveal a key role for the Ang-(1-7)/Mas axis as a modulator of cardiomyocyte function.
Key Words: ventricular cardiomyocytes NO Ca2+ transient Ang-(1-7), Mas
This article has been cited by other articles:
![]() |
Z. Kassiri, J. Zhong, D. Guo, R. Basu, X. Wang, P. P. Liu, J. W. Scholey, J. M. Penninger, and G. Y. Oudit Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction Circ Heart Fail, September 1, 2009; 2(5): 446 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Primola-Gomes, L. A. Campos, S. Lauton-Santos, C. H. Balthazar, S. Guatimosim, L. S. A. Capettini, V. S. Lemos, C. C. Coimbra, D. D. Soares, M. A. Carneiro-Junior, et al. Exercise capacity is related to calcium transients in ventricular cardiomyocytes J Appl Physiol, August 1, 2009; 107(2): 593 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Oudit, Y. Imai, K. Kuba, J. W. Scholey, and J. M. Penninger The role of ACE2 in pulmonary diseases--relevance for the nephrologist Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1362 - 1365. [Full Text] [PDF] |
||||
![]() |
J. A. Stewart Jr, E. Lazartigues, and P. A. Lucchesi The Angiotensin Converting Enzyme 2/Ang-(1-7) Axis in the Heart: A Role for Mas Communication? Circ. Res., November 21, 2008; 103(11): 1197 - 1199. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |